Pharmafile Logo
Pharmafocus logo
Advanced Search

Risk Based Inspections for good pharmacovigilance practice

October 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Recently in the UK there has been a move towards risk-based inspection programmes.  The scope, frequency and depth of MHRA …

News
Press release
Twitter feed

#fakedrugs: Scammers using Twitter to peddle fake medicines

October 24, 2011
Medical Communications Digital Pharma blog, Twitter

 Scammers are exploiting Twitter to entice people into buying fake medicines, according to a new report. The report, published by …

News
Lab image

Does drug development deliver on its promises?

October 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, R&D

I am always guided by the motto of the Royal Society, ‘Nullius in Verba’. This means, with typical Latin brevity: …

Feature

TranslateMedia listed in Deloitte UK Technology Fast 50 for 2011

October 24, 2011

The Deloitte UK Technology Fast 50 was founded in 1998, and remains one of Britain’s foremost technology programs. The program …

News
Press release
Merck image

Merck to invest $1billion in Singapore R&D and manufacturing

October 24, 2011
Manufacturing and Production, Research and Development

Singapore has reinforced its position as a major pharmaceutical hub for the Asia-Pacific region with the news that Merck is …

News

Bristol-Myers Squibb makes three senior management changes

October 24, 2011
Medical Communications, Research and Development, Sales and Marketing BMS

BMS has made three changes to its senior management with Giovanni Caforio promoted to president of US pharmaceuticals and Charles …

Appointment
Depakote

Abbott to pay $1.3 billion for Depakote lawsuits

October 24, 2011
Research and Development, Sales and Marketing Abbott, Depakote

 

News

Merck Serono returns Parkinson’s drug rights to Newron

October 24, 2011
Research and Development, Sales and Marketing Merck Serono, Newron

Merck Serono has returned the rights to the Parkinson’s disease drug safinamide back to Newron. The decision comes after the …

News

Number of CCGs continues to shrink

October 23, 2011
Sales and Marketing CCG, CCGs, NHS reform, clinical commissioning, primary care

The number of regional groups preparing to take over control of the NHS in England is rapidly shrinking, as the …

News

Amgen poaches Tony Hooper from Bristol-Myers Squibb

October 21, 2011
Medical Communications Amgen, BMS

Amgen has appointed Tony Hooper as the new executive vice president of global commercial operations. Hooper, 56, joins Amgen after …

Appointment

Abbott spin-off could attract mega merger

October 21, 2011
Research and Development, Sales and Marketing Abbott, Bayer, Humira, Merck, Roche

Abbott’s new spin-off pharma firm could attract a lot of attention from big pharma looking to sure up their portfolios. …

News
abpi

UK research cannot rest on its laurels, warns ABPI

October 21, 2011
Medical Communications, Research and Development ABPI, NHS, R&D

The ABPI has warned that the UK must continue to attract investment for research, or risk being superseded by emerging …

News
Abbott

Abbott to split into two separate companies

October 20, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Abbott Laboratories

Abbott’s management has decided to split the company into two separate entities in order to give shareholders a ‘distinct investment …

News
GSK

Rumours abound on GSK-HGS takeover bid

October 20, 2011
Research and Development, Sales and Marketing Benlysta, GSK, HGS

Rumours are gathering pace that GlaxoSmithKline may launch a takeover bid for struggling US firm Human Genome Sciences. British tabloid …

News
Herceptin image

Injectable Herceptin proves its worth

October 20, 2011
Research and Development, Sales and Marketing Herceptin, Roche

An injectable version of Roche’s breast cancer drug Herceptin compares favourably to the standard intravenous infusion, according to new research. …

News

Medical Devices: Harmonisation of Requirements for Address of Manufacturer

October 19, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The inclusion of the manufacturer’s address on the labels and instructions for use is an Essential Requirement according to the …

News
Press release

Opportunity to Realise the Value of Dormant UK Authorisations before December Deadline

October 19, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Holders wishing to cancel their authorisations, registrations and licences are required to notify the MHRA by 31 December 2011 to …

News
Press release
malaria vaccine trial

GSK malaria vaccine cuts disease risk by half

October 19, 2011
Research and Development malaria, malaria vaccine

Results from GSK’s malaria vaccine trial have excited observers after it reduced the risk of the disease by half. Data …

News

European judge rules against stem cell patents

October 19, 2011
Research and Development Stem cells, patents

The European Court of Justice has ruled that stem cells cannot be patented, representing a major blow to research in …

News

NHS hospital prescribing costs jump

October 19, 2011
Sales and Marketing hospital spending, prescribing

New and expensive treatments have driven up NHS prescribing costs in English hospitals, according to a new report. IMS Health …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026